Invention Grant
- Patent Title: Treatment of circadian rhythm disorders
-
Application No.: US17206811Application Date: 2021-03-19
-
Publication No.: US11833130B2Publication Date: 2023-12-05
- Inventor: Marlene Michelle Dressman , John Joseph Feeney , Louis William Licamele , Mihael H. Polymeropoulos
- Applicant: Vanda Pharmaceuticals Inc.
- Applicant Address: US DC Washington
- Assignee: VANDA PHARMACEUTICALS INC.
- Current Assignee: VANDA PHARMACEUTICALS INC.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- The original application number of the division: US16792275 2020.02.16
- Main IPC: A61K31/343
- IPC: A61K31/343 ; A61K31/00 ; A61K45/06 ; A61K31/15 ; A61K31/277 ; A61K31/496 ; G01N30/72 ; G16H50/20 ; G01N33/74 ; G01N33/68 ; A61K9/00
Abstract:
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Public/Granted literature
- US20210205261A1 TREATMENT OF CIRCADIAN RHYTHM DISORDERS Public/Granted day:2021-07-08
Information query
IPC分类:
